205 related articles for article (PubMed ID: 34367317)
21. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
23. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
24. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses.
Xiao Y; Zhu Z; Li J; Yao J; Jiang H; Ran R; Li X; Li Z
Aging (Albany NY); 2020 Feb; 12(4):3407-3430. PubMed ID: 32081833
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
26. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.
Ding Y; Jiang Y; Zeng H; Zhou M; Zhou X; Yu Z; Pan J; Geng X; Zhu Y; Zheng H; Huang S; Gong Y; Huang H; Xiong C; Huang D
Aging (Albany NY); 2024 Apr; 16(8):6954-6989. PubMed ID: 38613802
[TBL] [Abstract][Full Text] [Related]
27. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract][Full Text] [Related]
28. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
Xu B
Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
30. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
31. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p.
Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F
Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942
[TBL] [Abstract][Full Text] [Related]
32. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
33. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
34. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
Akçay S; Güven E; Afzal M; Kazmi I
Gene; 2022 May; 824():146395. PubMed ID: 35283227
[TBL] [Abstract][Full Text] [Related]
35. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Xia P; Li Q; Wu G; Huang Y
J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
[TBL] [Abstract][Full Text] [Related]
36. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
Xing W; Zeng C
Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
[TBL] [Abstract][Full Text] [Related]
37. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
38. Transcriptome analysis revealed CENPF associated with glioma prognosis.
Zhang M; Zhang Q; Bai J; Zhao Z; Zhang J
Math Biosci Eng; 2021 Mar; 18(3):2077-2096. PubMed ID: 33892537
[TBL] [Abstract][Full Text] [Related]
39. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
Güven E; Afzal M; Kazmi I
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
[TBL] [Abstract][Full Text] [Related]
40. Identification of
Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]